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Abstract
Background: In a typical genome-enabled prediction problem there are many more predictor variables than
response variables. This prohibits the application of multiple linear regression, because the unique ordinary least
squares estimators of the regression coefficients are not defined. To overcome this problem, penalized regression
methods have been proposed, aiming at shrinking the coefficients toward zero.
Methods: We explore prediction of phenotype from single nucleotide polymorphism (SNP) data in the GAW20
data set using a penalized regression approach (LASSO [least absolute shrinkage and selection operator] regression).
We use 10-fold cross-validation to assess predictive performance and 10-fold nested cross-validation to specify a
penalty parameter.
Results: By analyzing approximately 600,000 SNPs we find that, when the sample size comprises a few hundred
individuals, SNP effects are heavily penalized, resulting in a poor predictive performance. Increasing the sample size to a
few thousand individuals results in a much smaller penalization of the true effects, thus greatly improving the prediction.
Conclusions: LASSO regression results in a heavy shrinkage of the regression coefficients, and also requires large sample
sizes (several thousand individuals) to achieve good prediction.
Background
In a typical genome-wide association study (GWAS), sev-
eral thousands to several millions of single nucleotide poly-
morphism (SNP) markers are genotyped in a sample size of
several hundred to several thousand individuals, thus lead-
ing to many more predictor variables than response vari-
ables. In this case, multiple linear regression cannot be used
because the unique ordinary least squares estimators of the
regression coefficients are not defined. Methods that allow
for more predictors than observations [1] may cause model
overfitting. Overfitted models are likely to demonstrate
poor predictive ability when applied to new data. To over-
come these problems, penalized regression methods have
been proposed [2–6], aiming at shrinking the regression co-
efficients toward zero. Depending on the form of the pen-
alty function, some methods (eg, ridge regression [3]) only
shrink the coefficients without setting them to zero,
whereas other methods (eg, the least absolute shrinkage
and selection operator [LASSO] regression [2]) allow
shrinkage of the coefficients down to exactly zero, thus per-
forming variable selection.
The strength of the penalty is controlled by a
regularization parameter that determines the amount of
shrinkage imposed. One challenge of penalized ap-
proaches is choosing an optimal value of the
regularization parameter. This is often done by k-fold
cross-validation to find the parameter value in the train-
ing folds that minimizes the average mean squared error
in the test folds. Assessing the predictive performance
can also be done using k-fold cross-validation. In this
case, the two cross-validation experiments are combined
into one so-called nested cross-validation. In nested
cross-validation, an outer cross-validation loop is used to
assess the predictive performance, while, within each
outer fold, an inner cross-validation loop is used to find
the regularization parameter [7]. The most commonly* Correspondence: svetlana.cherlin@ncl.ac.uk
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used number of inner and outer folds is 10 because it pro-
vides a reasonable classification accuracy [8].
Here, we focus on LASSO linear regression, which has
the property of variable selection. We apply 10-fold
cross-validation to assess the out-of-sample predictive per-
formance, using 10-fold nested cross-validation to specify
the penalty parameter. We explore the effect of the sample
size on the predictive ability of LASSO regression.
Methods
The GAW20 data are based on the Genetics of Lipid
Lowering Drugs and Diet Network (GOLDN) study data
set [9] that investigated the epigenetic determinants of
triglyceride (TG) response. TGs are major blood lipids
[10] that constitute an important biomarker of cardio-
vascular disease risk [11]. Previous GWAS studies found
a number of loci associated with TG levels [12]. We
focus on predicting the TG response by analyzing the
GWAS (SNP) data and four measures of TG. The first
two measures (at visits 1 and 2) were taken before the
lipid-lowering drug treatment; the second two measures
(at visits 3 and 4) were taken after the treatment.
We performed quality control (QC) on the GAW20
GWAS (SNP) data using standard procedures outlined in
Turner et al. [13]. SNP-level QC removes 63,907 SNPs
with low minor allele frequency (< 0.01), and 2694 SNPs
for failing a test of Hardy-Weinberg equilibrium (p ≤
0.00001). Of 822 individuals for whom we have SNP data,
the simulated phenotype is available for 680 individuals
and the real phenotype is available for 778 individuals.
Working on a log scale, we take the mean of the TG mea-
sures for visits 1 and 2 as a baseline measure, and the
mean of visits 3 and 4 as a follow-up measure. If the
measure for either visit 1 or 2 is not available, we take the
only available measure as a baseline measure. Similarly, if
the measure for either visit 3 or 4 is not available, we take
the only available measure as a follow-up measure. We ad-
just the follow-up measure for the baseline measure, age,
center, smoking status, and first 20 principal components
(PCs) of SNP effects using a linear regression. The num-
ber of PCs was defined by examining the quantile–
Fig. 1 Analysis of the GAW20 simulated data, replicate 84. a, Manhattan plot of p values from tests of association between SNP and phenotype.
The black dots represent causal SNPs. The dashed line represents genome-wide significance. b, Prediction results. The black dashed line is the
equality line; the red dashed line is the best-fit line
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quantile (Q-Q) plot of the p values from the ordinary lin-
ear regression. When 20 PCs were incorporated into the
linear regression, the Q-Q plot showed no inflated p
values, which suggests that the relatedness and population
stratification are accounted for. We take the standardized
residuals as our final phenotype.
Lasso
Consider a standard multiple linear regression, y = β0 +
Xβ + ϵ, where y is a vector of response variables; X is a
n × p matrix of predictor variables; β0 is an intercept; β
= (β1,…, βp) is a vector of regression coefficients; and ϵ
is a vector of the error terms, ϵ~N(0, σ2). For n > p the
estimated values of the coefficients are found by minim-
izing the residual sum of squares:
β^o; β^ ¼ argmin
Xn
i¼1 yi−βo−
Xp
j¼1β jXij
 2 
However, in a typical GWAS, n < p. In this case, penal-
ized regression is often used, where the estimators of β
are found by minimizing the sum of the residual sum of
squares and a penalty function:
β^o; β^ ¼ argmin
Xn
i¼1 yi−βo−
Xp
j¼1β jXij
 2
þ λP λ;βð Þ
 
Here P(λ, β) is the penalty function with a
regularization parameter λ which controls the amount of
shrinkage. The LASSO penalty [2] utilizes an ℓ1-norm
penalty, that is, Pðλ; βÞ ¼ ‖β‖ ℓ1 ; consequently, the esti-
mators of the coefficients take the form:
β^o; β^ ¼ argmin
Xn
i¼1 yi−βo−
Xp
j¼1β jXij
 2
þ λ
Xp
j¼1jβ jj
 
One important property of the LASSO penalty is that
it allows the coefficients to be set to exactly zero, thus
performing variable selection.
Fig. 2 Analysis of the subset of the illustrative simulated data set (700 individuals). a, Manhattan plot of p values from tests of association
between SNP and phenotype. The black dot represents the causal SNP. The dashed line represents genome-wide significance. b, Prediction results.
The black dashed line is the equality line; the red dashed line is the best-fit line
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Results
Simulated data
We analyzed replicate 84 of the simulated data, consulting
the “answers” before performing the analysis. The Man-
hattan plot from standard linear regression shows no
genome-wide significant associations, however, one of the
known causal SNPs is nearly genome-wide significant
(Fig. 1a). We applied LASSO regression on these data and
assessed the predictive performance through 10-fold
nested cross-validation, after reducing the number of
SNPs to approximately 56,000 using a linkage disequilib-
rium (LD)–based clumping procedure implemented in the
PLINK software [14]. This procedure groups correlated
SNPs together and chooses one representative SNP per
group, thus reducing dimensionality and eliminating the
redundancy of information in the data. We assessed the
prediction accuracy through the Pearson correlation coef-
ficient (the square root of heritability), the mean squared
error (lower values indicate better fit), and the slope of the
best-fit line (a slope of 1 suggests perfect prediction).
Figure 1b shows that the predicted phenotypes are heavily
shrunk toward zero, resulting in a very low correlation be-
tween observed and predicted values and a slope that is
far from 1. Poor prediction can be explained by the fact
that the effect (regression coefficient) of the most signifi-
cant true causal SNP is heavily shrunk (a mean estimate
of − 0.051 and a SD of 0.062 over the 10 folds, compared
to a mean estimate of − 0.443 and a SD of 0.02 over the
10 folds in standard linear regression).
To investigate whether increasing the sample size can
improve the prediction, we simulated phenotypes for 7753
individuals for whom we had SNP genotype data available
from previous studies. The phenotypes were simulated
using only 1 causal SNP with an effect size of − 0.44 (simi-
lar to the effect of the nearly genome-wide significant
causal SNP from the GAW20 simulated data) and herit-
ability of 0.05, which induces a correlation of approxi-
mately 0.23 between the observed and the predicted
phenotype. First, we analyzed a subset of these data com-
prising 700 individuals (similar to the sample size of the
Fig. 3 Analysis of the illustrative simulated data set (7753 individuals). a, Manhattan plot of p values from tests of association between SNP and
phenotype. The black dot represents the causal SNP. The dashed line represents genome-wide significance. b, Prediction results. The black dashed
line is the equality line; the red dashed line is the best-fit line
Cherlin et al. BMC Proceedings 2018, 12(Suppl 9):38 Page 226 of 258
GAW20 simulated data). The results resemble those seen
in the GAW20 simulated data (Fig. 2). Even though the
causal SNP is consistently picked up by LASSO, its effect
is poorly estimated (the mean estimate is − 0.096 and the
SD is 0.019 over the 10 folds) and has the same order of
magnitude as the SNPs (false positive) chosen by LASSO,
resulting in poor prediction. We then repeat the analysis
using the full sample (7753 individuals). The Manhattan
plot shows that the significance of the causal SNP has
greatly increased (Fig. 3a). The prediction plots show three
distinct clusters representing the estimated effects within
the three genotype categories of the causal SNP (Fig. 3b).
The effect of the causal SNP is much better estimated (the
mean estimate is − 0.247 and the SD is 0.009 over the 10
folds) and the effect size is 10 to 1000 times greater than
that of the non-causal SNPs falsely chosen by LASSO.
The range of the regularization parameter across folds for
the full data set (0.046 to 0.056) is smaller than that for
the subset (0.081 to 0.183). This suggests that the regres-
sion coefficients for the full data set are much less penal-
ized, greatly improving the prediction.
Real data
We also applied LASSO regression to the real GAW20
data and assessed the predictive performance through
10-fold nested cross-validation, after again reducing the
number of SNPs to approximately 56,000 using an
LD-based clumping procedure. The Manhattan plot
shows no genome-wide significant associations (Fig. 4a)
and it resembles the Manhattan plot of the GAW20 simu-
lated data. The prediction results are very similar to the
results seen in the GAW20 simulated data (Fig. 4b). In a
sense, these results are not surprising given the similar
sample sizes of the simulated and the real data sets.
Discussion
The prediction ability of LASSO was assessed on the sim-
ulated and the real GAW20 data sets through 10-fold
nested cross-validation. Both data sets demonstrated poor
predictive performance and exhibited a noticeable shrink-
age of the predicted phenotype toward zero. By examining
the effect of the most significant causal SNP in the simu-
lated data, we found that it was heavily penalized. To
Fig. 4 Analysis of the GAW20 real data set. a, Manhattan plot of p values from tests of association between SNP and phenotype. The dashed line
represents genome-wide significance. b, Prediction results. The black dashed line is the equality line; the red dashed line is the best-fit line
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investigate this issue, we analyzed a much larger data set
(approximately 7000 individuals). We found that the effect
of the causal SNP was much less penalized, thus enabling
the best prediction possible with that SNP.
Conclusions
The prediction ability of LASSO was assessed on the
GAW20 data sets and on the much larger data set avail-
able from previous studies. Poor predictive performance
is achieved for data sets of a few hundred individuals
with a weak signal. This can be explained by the fact that
the LASSO regression coefficients are substantially
shrunk. Other regularized methods that do not result in
such a heavy shrinkage of the regression coefficients
might be of use. For example, with hyper-LASSO [6] the
extent of the shrinkage depends on the size of the coeffi-
cients, and adaptive LASSO [5] uses different adaptive
weights for penalizing different coefficients. Both of
these can potentially lead to a moderate shrinkage. How-
ever, with LASSO, increasing the sample size from a few
hundred to a few thousand individuals increased the
strength of the signal and reduced the amount of shrink-
age of the regression coefficients, thus improving the
prediction. We conclude that LASSO regression requires
large sample sizes (several thousands of individuals) to
achieve good prediction.
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